Weight-Loss Drugs Have Negligible Impact on PepsiCo Sales, CEO States
October 11, 2023
PepsiCo’s CEO, Ramon Laguarta, has stated that the impact of weight-loss drugs like Ozempic and Wegovy on their sales has been minimal so far. While acknowledging some uncertainty about the long-term effects of these drugs on consumer behavior, the company remains watchful of the trend. Laguarta highlighted a shift toward more snacking and mini-meals, particularly among urban, middle-class consumers, as a positive development for PepsiCo.
Recent News
New Starbucks Artist Collaboration Merch Announced
Inspired by personal experiences and cultural heritage, artist Monyee Chau brings forth a collection under the Starbucks Artist Collaboration Series set to debut this summer.
FDA Says Eating Yogurt May Help With One Common Disease
The Food and Drug Administration claims that yogurt could help with one common disease, but there’s a catch as to not mislead consumers.
Climeworks Unveils ‘World’s Largest’ Carbon Capture Plant
Amidst the global climate crisis, a groundbreaking solution emerges: the inauguration of the world’s largest carbon capture plant, “Mammoth,” in Iceland. Developed by Climeworks, this plant marks a significant stride in the pursuit of curbing planet-heating emissions.
Palmer Candy Company Recalls 29 Products for Possible Salmonella Contamination
The Food and Drug Administration (FDA) has recalled 29 of Palmer Candy Company’s white-coated confectionary items because of the potential for salmonella contamination.